Splenic Procedures with CC DRG - Reimbursement Guide

DRG 800 encompasses inpatient admissions for splenic procedures when a Complication or Comorbidity is present, covering splenectomy and related operative care. This Diagnosis-Related Group matters because the Complication or Comorbidity status increases resource use and determines Medicare prospective payment classification.

DRG 800 Overview

DRG 800 covers inpatient admissions involving splenic procedures performed for therapeutic or diagnostic reasons when a Complication or Comorbidity is present. The clinical scope includes splenectomy, partial splenectomy, splenic repair, and related operative management in the setting of additional clinical complexity. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity elevates resource intensity and affects prospective payment classification under Centers for Medicare & Medicaid Services rules. Accurate coding and documentation of the splenic procedure and the Complication or Comorbidity drive payment assignment for these hospital stays.

DRG 800 Overview

Acute hemostatic intervention studies: randomized or prospective cohort trials comparing different operative and perioperative strategies to control hemorrhage from traumatic or nontraumatic splenic injury (for example, rapid splenectomy versus splenic salvage procedures such as partial splenectomy or repair). These studies target hemodynamically unstable patients or those with significant concomitant injuries, assessing outcomes like operative time, transfusion requirements, in-hospital mortality, and complication rates. Results inform surgeons, hospital administrators, and payers about resource use and short-term outcomes that drive inpatient costs and admission intensity for this DRG.
Comparative effectiveness studies of perioperative management and complication reduction: observational or pragmatic trials evaluating approaches such as infection prophylaxis protocols, thromboprophylaxis regimens, and standardized postoperative care pathways in patients undergoing splenic procedures with complicating conditions (the CC component may include sepsis, coagulopathy, or major comorbidity). These studies enroll a broader, often older or comorbid inpatient population to compare rates of surgical site infection, venous thromboembolism, length of stay, and readmission. Findings are relevant for clinicians and payers because optimizing perioperative protocols can reduce complications, shorten stays, and lower reimbursement-related expenditures for cases classified under this DRG.
Post-discharge outcomes and immunologic sequelae research: longitudinal cohort studies or registry analyses that follow patients after splenic removal or significant splenic injury to assess long-term risks such as overwhelming post-splenectomy infection, vaccine response, and quality of life, as well as utilization of outpatient preventive care (vaccination, antibiotic prophylaxis) and readmissions. These studies focus on survivors of index hospitalization—often patients with complex comorbidity profiles—and evaluate how inpatient education and discharge planning affect downstream infections and healthcare use. This research matters to providers and payers because preventing late infectious complications and avoidable readmissions influences total cost of care and value-based performance metrics tied to this DRG.

Acute hemostatic intervention studies: randomized or prospective cohort trials comparing different operative and perioperative strategies to control hemorrhage from traumatic or nontraumatic splenic injury (for example, rapid splenectomy versus splenic salvage procedures such as partial splenectomy or repair). These studies target hemodynamically unstable patients or those with significant concomitant injuries, assessing outcomes like operative time, transfusion requirements, in-hospital mortality, and complication rates. Results inform surgeons, hospital administrators, and payers about resource use and short-term outcomes that drive inpatient costs and admission intensity for this DRG.
Comparative effectiveness studies of perioperative management and complication reduction: observational or pragmatic trials evaluating approaches such as infection prophylaxis protocols, thromboprophylaxis regimens, and standardized postoperative care pathways in patients undergoing splenic procedures with complicating conditions (the CC component may include sepsis, coagulopathy, or major comorbidity). These studies enroll a broader, often older or comorbid inpatient population to compare rates of surgical site infection, venous thromboembolism, length of stay, and readmission. Findings are relevant for clinicians and payers because optimizing perioperative protocols can reduce complications, shorten stays, and lower reimbursement-related expenditures for cases classified under this DRG.
Post-discharge outcomes and immunologic sequelae research: longitudinal cohort studies or registry analyses that follow patients after splenic removal or significant splenic injury to assess long-term risks such as overwhelming post-splenectomy infection, vaccine response, and quality of life, as well as utilization of outpatient preventive care (vaccination, antibiotic prophylaxis) and readmissions. These studies focus on survivors of index hospitalization—often patients with complex comorbidity profiles—and evaluate how inpatient education and discharge planning affect downstream infections and healthcare use. This research matters to providers and payers because preventing late infectious complications and avoidable readmissions influences total cost of care and value-based performance metrics tied to this DRG.

OpenPayer

Splenic Procedures with CC: Inpatient Reimbursement Overview

Sign up for drg 800 policy alerts

DRG 800 Overview

OpenPayer

Splenic Procedures with CC: Inpatient Reimbursement Overview

Sign up for drg 800 policy alerts

DRG 800 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References